Chemkart India IPO GMP Today – Price Band, Lot Size, Dates & Subscription Update 2025
Chemkart India IPO GMP is currently stable, drawing cautious optimism from investors. As a B2B distributor of nutrition, food, and sports supplement ingredients, Chemkart India Limited has launched its IPO on the BSE SME platform, aiming to tap into India’s fast-growing health and wellness sector. This IPO is gaining attention among retail and HNI investors, especially those eyeing long-term growth in niche sectors.
🔸 Chemkart India IPO GMP Today
As of now, the Chemkart India IPO GMP is ₹0, indicating a neutral stance in the grey market. While not signaling strong listing gains immediately, the flat GMP shows investors are watching closely for updates on demand and subscription momentum.
🔸 Chemkart India IPO Price Band & Lot Size
-
Price Band: ₹236 – ₹248 per equity share
-
Lot Size: 600 shares
-
Minimum Investment (1 lot): ₹1,48,800 (at the upper band)
-
Face Value: ₹10 per share
The IPO appears fairly priced, particularly when considering the company’s consistent revenue and operational scale in a high-demand B2B sector.
Chemkart India IPO Timeline
About Chemkart India Limited
Chemkart India Ltd is a Mumbai-based B2B supplier specializing in food, health, herbal, and sports nutrition ingredients. Its diverse product range includes:
-
Amino acids
-
Vitamins & minerals
-
Herbal extracts
-
Protein blends and sports nutrition raw materials
Operating from a 28,000+ sq. ft. facility in Bhiwandi, Chemkart provides blending, packaging, and private labeling services to both startups and global brands.
IPO Objective
The IPO proceeds will be used for:
-
Working capital requirements
-
Warehouse expansion
-
Equipment upgrades
-
General corporate purposes
This capital infusion aims to boost Chemkart’s operational efficiency and logistics infrastructure.
Subscription Status
On Day 1, Chemkart India IPO witnessed steady interest, with most traction coming from retail investors. Although the Chemkart India IPO GMP is flat, further subscription data and grey market trends will play a key role in shaping listing expectations.
Should You Invest in Chemkart India IPO?
Chemkart India offers a niche opportunity in the fast-growing nutrition and health segment. While the GMP of ₹0 signals cautious investor sentiment, the company's fundamentals and B2B distribution model present strong long-term potential. It may appeal more to investors with a long-term horizon and confidence in India’s wellness ecosystem.
Conclusion
The Chemkart India IPO GMP today suggests a “wait-and-watch” mode in the grey market. However, with its strong B2B business model, strategic warehouse facility, and product diversity, Chemkart presents a compelling case for long-term SME investors. Stay tuned with Finowings for daily GMP updates, allotment status, and listing insights.
FAQs – Chemkart India IPO GMP
1. What is the Chemkart India IPO GMP today?
The Chemkart India IPO GMP is currently ₹0, indicating neutral grey market sentiment.
2. What is the IPO price band and lot size?
The IPO is priced between ₹236–₹248 per share, with a lot size of 600 shares.
3. What is the minimum investment in Chemkart India IPO?
At the upper band of ₹248, the minimum investment for 1 lot (600 shares) is ₹1,48,800.
4. When will Chemkart India IPO open and close?
The IPO opens on July 7, 2025, and closes on July 9, 2025.
5. When is the Chemkart India IPO listing date?
The IPO will be listed on the BSE SME platform on July 14, 2025.
Comments
0 comment